MOSCOW (Reuters) – Russia’s health ministry has approved a trial of the Sputnik V vaccine against COVID-19 on 110 volunteers over the age of 60, the RIA news agency cited the ministry as saying on Tuesday.
The testing will be conducted alongside an ongoing late-stage trial, known as a Phase III, of the vaccine on 40,000 volunteers in Moscow.
(Reporting by Polina Devitt; Writing by Polina Ivanova; Editing by Catherine Evans)
